分析痤疮引流术后瘢痕防治的最佳途径,探讨综合治疗法与常规治疗法的疗效对比,运用医学实验观测手段,在2023年5月至2024年5月期间,随机抽取180名痤疮引流术后留下的瘢痕患者,作为研究样本,将样本均等分割为实验组和对照组。对照组实施了标准治疗方案,综合了抗瘢痕药物、瘢痕贴剂及激光治疗等多种治疗法;实验组采用了综合治疗法,涉及硅胶粘贴、弹力护套、硅酮类产品、瘢痕皮下注射治疗、点阵激光手术及手术治疗等多种技术。治疗后,审视并对比两组病患的永久性瘢痕发生率、患者满意度以及术后并发症和不良反响,永久性瘢痕的发生率仅为1.11% (即90人中有1人),对照组数据减少了20.00% (18/90)之多,数据对比分析表明,差异显著(P The objective of this study was to analyse the most effective methods for preventing and controlling scars after drainage surgery. In addition, the efficacy of integrated treatment methods was compared with that of conventional treatment methods. To this end, 180 patients with scars resulting from acne drainage were randomly selected as a study sample between May 2023 and May 2024. The samples were divided equally into an experimental group and a control group. The control group underwent a standard treatment protocol comprising a range of techniques, including the use of anti-scar medications, scar patches and laser therapy. In contrast, the experimental group received a combination of treatments involving various techniques, such as silicone paste, elasticated sheaths, silicone-based products, subcutaneous injection treatment of scars, fractional laser surgery and surgical treatment. Following treatment, the incidence of permanent scarring, patient satisfaction, and postoperative complications and adverse reactions in the two groups of patients were examined and compared. The incidence of permanent scarring was found to be only 1.11% (namely, 1 out of 90 people). Furthermore, the data for
近年来,A型肉毒杆菌毒素(botulinum toxin type A,BTXA)在瘢痕的治疗中引起了广泛的讨论和关注,本综述旨在讨论近5年以来国内外学者对BTXA在各类瘢痕防治中的应用及研究。其中,BTXA在术后瘢痕的应用最为普遍,术后早期、更高剂量的注射方法能达到更好的疗效。BTXA对瘢痕疙瘩、增生性瘢痕具一定的治疗潜力,联合其他治疗方法能达到更好的治疗效果,其最常与局部皮质类固醇注射联合,及与微针、二氧化碳点阵激光、光动力联合治疗。总体而言,BTXA对各类瘢痕的疗效良好,不良反应少,但作用机制尚不明确,仍需进一步研究。
